Israeli COVID-19 Vaccine Developer Begins Phase II Trial In Georgia
The BriLife jabs arrived in Georgia over the weekend to begin the trial, which will run simultaneously with trials in Israel.
August 15, 2021
Israeli COVID-19 Vaccine Developer Inks Deal To Complete Trials, Commercialize Jab
The BriLife vaccine will be tested in Phase II and III trials in Georgia, Ukraine, and Israel as part of a deal with NRx Pharmaceuticals.
July 13, 2021
Israeli COVID-19 Vaccine Developer Said Aiming For Single Dose, May Redo Trials
Scientists at the Israel Institute for Biological Research are looking into forgoing a second vaccine jab if a higher dose is given initially.
May 09, 2021